Diabetic pregnancy: An overview of current guidelines and clinical practice

Current Opinion in Obstetrics and Gynecology

Volumn 26, Issue 6, 2014, Pages 431-437

  Skupień, Jan ^a   Cyganek, Katarzyna ^b   Małeckia, Maciej T ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^b UNIVERSITY HOSPITAL IN KRAKOW   (Poland)

Author keywords

Clinical practice guidelines; Diabetes diagnosis; Diabetes in pregnancy; Gestational diabetes mellitus

Indexed keywords

INSULIN; INSULIN GLULISINE; LONG ACTING INSULIN; METFORMIN; ORAL ANTIDIABETIC AGENT; SULFONYLUREA; ANTIDIABETIC AGENT; HUMAN INSULIN; RECOMBINANT PROTEIN;

CLINICAL PRACTICE; COST; FEMALE; GLUCOSE BLOOD LEVEL; HEALTH CARE COST; HUMAN; INSULIN TREATMENT; MACROSOMIA; PATIENT MONITORING; PRACTICE GUIDELINE; PREGNANCY DIABETES MELLITUS; PREGNANCY OUTCOME; PREVALENCE; PRIORITY JOURNAL; REVIEW; ANALOGS AND DERIVATIVES; CHEMISTRY; CONSENSUS; DIABETES, GESTATIONAL; DIABETIC DIET; EVIDENCE BASED MEDICINE; FETAL MACROSOMIA; GENETICS; HEALTH; MATERNAL NUTRITION; MULTIMODALITY CANCER THERAPY; PATHOPHYSIOLOGY; POPULATION DYNAMICS; PREGNANCY; PREGNANCY IN DIABETICS; PRENATAL DIAGNOSIS; RISK; TRENDS;

COMBINED MODALITY THERAPY; CONSENSUS; DIABETES, GESTATIONAL; DIABETIC DIET; EVIDENCE-BASED MEDICINE; FEMALE; FETAL MACROSOMIA; GLOBAL HEALTH; HEALTH TRANSITION; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN, REGULAR, HUMAN; MATERNAL NUTRITIONAL PHYSIOLOGICAL PHENOMENA; PRACTICE GUIDELINES AS TOPIC; PREGNANCY; PREGNANCY IN DIABETICS; PRENATAL DIAGNOSIS; RECOMBINANT PROTEINS; RISK;

EID: 84928075657     PISSN: 1040872X     EISSN: 1473656X     Source Type: Journal    
DOI: 10.1097/GCO.0000000000000111     Document Type: Review

References (58)

1. Danaei G, Finucane M, Lu Y, et al. Burden of Metabolic Risk Factors of Chronic Diseases Collaborating Group (Blood Glucose). National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2-7 million participants. Lancet 2011; 378:31-40.
2. Cheng YJ, Imperatore G, Geiss LS, et al. Secular changes in the age-specific prevalence of diabetes among U.S. adults: 1988-2010. Diabetes Care 2013; 36:2690-2696.
3. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 2003; 26 Suppl 1:S5-S20.
4. Erlinger T, Brancati F. Postchallenge hyperglycemia in a national sample of U.S. adults with type 2 diabetes. Diabetes Care 2001; 24:1734-1738.
5. Saydah S, Miret M, Sung J, et al. Postchallenge hyperglycemia and mortality in a national sample of U.S. adults. Diabetes Care 2001; 24:1397-1402.
6. Definition, diagnosis and classification of diabetes mellitus and its complications. Geneva: World Health Organization; 1999.
7. Bell R, Bailey K, Cresswell T, et al. Northern Diabetic Pregnancy Survey Steering Group. Trends in prevalence and outcomes of pregnancy in women with preexisting type I and type II diabetes. BJOG 2008; 115:445-452.
8. Feig DS, Razzaq A, Sykora K, et al. Trends in deliveries, prenatal care, and obstetrical complications in women with pregestational diabetes. a populationbased study in Ontario, Canada, 1996-2001. Diabetes Care 2006; 29:232-235.
9. Garne E, Loane M, Dolk H, et al. Spectrum of congenital anomalies in pregnancies with pregestational diabetes. Birth Defects Res A Clin Mol Teratol 2012; 94:134-140.
10. DeSisto CL, Kim SY, Shrama AJ. Prevalence estimates of gestational diabetes mellitus in the United States: Pregnancy Risk Assessment Monitoring System (PRAMS), 2007-2010. Prev Chronic Dis 2014; 11:E104.
11. Bardenheier BH, Elixhauser A, Imperatore G, et al. Variation in prevalence of gestational diabetes mellitus among hospital discharges for obstetric delivery across 23 states in the United States. Diabetes Care 2013; 36:1209-1214.
12. Kalter-Leibovici O, Freedman LS, Olmer L, et al. Screening and diagnosis of gestational diabetes mellitus: critical appraisal of the new International Association of Diabetes in Pregnancy Study Group recommendations on a national level. Diabetes Care 2012; 35:1894-1896.
13. O'Sullivan EP, Avalos G, O'Reilly M, et al. Atlantic DIP collaborators. Atlantic Diabetes in Pregnancy (DIP): the prevalence and outcomes of gestational diabetes mellitus using new diagnostic criteria. Diabetologia 2011; 54:1670-1675.
14. Benhalima K, Van Crombrugge P, Verhaeghe J, et al. The Belgian Diabetes in Pregnancy study (BEDIP-N): a multicentric prospective cohort study on screening for diabetes in pregnancy and gestational diabetes: methodology and design. BMC Pregnancy Childbirth 2014; 14:226.
15. Guariguata L, Linnenkamp U, Beagley J, et al. Global estimates of the prevalence of hyperglycaemia in pregnancy. Diabetes Res Clin Pract 2014; 103:176-185.
16. Barbour LA, McCurdy CE, Hernandez TL, et al. Cellular mechanisms for insulin resistance in normal pregnancy and gestational diabetes. Diabetes Care 2007; 30 (Suppl 2):S112-S119.
17. Ben-Haroush A, Yogev Y, Hod M. Epidemiology of gestational diabetes mellitus and its association with type 2 diabetes. Diabet Med 2004; 21:103-113.
18. Balsells M, Garcia-Patterson A, Gich I, Corcoy R. Maternal and fetal outcome in women with type 2 versus type 1 diabetes mellitus: a systematic review and meta-analysis. J Clin Endocrinol Metabol 2009; 94:4284-4291.
19. Balsells M, Garcia-Patterson A, Gich I, Corcoy R. Major congenital malformations in women with gestational diabetes mellitus: a systematic review and meta-analysis. Diabetes Metab Res Rev 2012; 28:252-257.
20. Hartling L, Dryden DM, Guthrie A, et al. Diagnostic thresholds for gestational diabetes and their impact on pregnancy outcomes: a systematic review. Diabet Med 2014; 31:319-331.
21. Tennant P, Glinianaia SV, Bilous RW, et al. Pre-existing diabetes, maternal glycated haemoglobin, and the risks of fetal and infant death: a populationbased study. Diabetologia 2014; 57:285-294.
22. Hoet JP, Lukens FD. Carbohydrate metabolism during pregnancy. Diabetes 1954; 3:1-12.
23. Carrington ER, Shuman CR, Reardon HS. Evaluation of the prediabetic state during pregnancy. Obstet Gynecol 1957; 9:664-669.
24. O'Sullivan J, Mahan C. Criteria for the oral glucose tolerance test in pregnancy. Diabetes 1964; 13:278-285.
25. Diabetes in pregnancy. Management of diabetes and its complications from preconception to the postnatal period. National Collaborating Centre for Women's and Children's Health. Commissioned by the National Institute for Health and Clinical Excellence. London: RCOG Press; 2008.
26. American Diabetes Association. Standards of medical care in diabetes: 2010. Diabetes Care 2010; 33 (Suppl 1):S11-S61.
27. National Diabetes Data Group. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 1979; 28:1039-1057.
28. Carpenter MW, Coustan DR. Criteria for screening tests for gestational diabetes. Am J Obstet Gynecol 1982; 144:768-773.
29. HAPO Study Cooperative Research Group. Metzger BE, Lowe LP, Dyer AR, et al. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med 2008; 358:1991-2002.
30. International Association of Diabetes and Pregnancy Study Groups. International Association of Diabetes and Pregnancy Study Groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care 2010; 33:676-682.
31. American Diabetes Association. Standards of medical care in diabetes: 2011. Diabetes Care 2011; 34 (Suppl 1):S11-S61.
32. Committee on Practice Bulletins-Obstetrics. Practice bulletin no. 137: gestational diabetes mellitus. Obstet Gynecol 2013; 122:406-416. Current clinical practice recommendation from the American College of Obstetrics and Gynecology.
33. Diagnostic criteria and classification of hyperglycaemia first detected in pregnancy. Geneva: World Health Organization; 2013. The newest definition and diagnostic criteria of gestational diabetes mellitus.
34. American Diabetes Association. Standards of medical care in diabetes: 2014. Diabetes Care 2014; 37 (Suppl 1):S14-S80. Current standards of care in diabetes from the ADA. It contains seven alternative definitions and diagnostic algorithms of gestational diabetes.
35. Vandorsten JP, Dodson WC, Espeland MA, et al. NIH consensus development conference: diagnosing gestational diabetes mellitus. NIH Consens State Sci Statements 2013; 29:1-31. A statement against the IADPSG diagnostic criteria of gestational diabetes.
36. Mission JF, Ohno MS, Cheng YW, Caughey AB. Gestational diabetes screening with the new IADPSG guidelines: a cost-effectiveness analysis. Am J Obstet Gynecol 2012; 207:326e1-326e9.
37. Werner EF, Pettker CM, Zuckerwise L, et al. Screening for gestational diabetes mellitus: are the criteria proposed by the international association of the Diabetes and Pregnancy Study Groups cost-effective? Diabetes Care 2012; 35:529-535.
38. International Diabetes Federation Clinical Guidelines Task Force. Global guideline on pregnancy and diabetes. Brussels: International Diabetes Federation; 2009.
39. Klemetti M, Nuutila M, Tikkanen M, et al. Trends in maternal BMI, glycaemic control and perinatal outcome among type 1 diabetic pregnant women in 1989-2008. Diabetologia 2012; 55:2327-2334.
40. Owens LA, Avalos G, Kirwan B, et al. ATLANTIC DIP: closing the loop: a change in clinical practice can improve outcomes for women with pregestational diabetes. Diabetes Care 2012; 35:1669-1671.
41. Cyganek K, Katra B, Skupien J, et al. Recent secular trend in treatment and glycemic control in women with type 1 diabetes during pregnancy: one center observation from Poland. American Diabetes Association 73rd Scientific Sessions [Abstract 1371-P].
42. Evers IM, de Valk HW, Mol BW, et al. Macrosomia despite good glycaemic control in type I diabetic pregnancy: results of a nationwide study in The Netherlands. Diabetologia 2002; 45:1484-1489.
43. Secher AL, Parellada CB, Ringholm L, et al. Maternal gestational weight gain and offspring birth weight in women with type 1 diabetes. American Diabetes Association 74th Scientific Sessions [Abstract 1281-P].
44. Cyganek K, Hebda-Szydlo A, Skupien J, et al. Risk factors of macrosomia in type 1 diabetes pregnancy: a retrospective analysis of one center in the years 1998-2012. American Diabetes Association 73rd Scientific Sessions [Abstract 1378-P].
45. Nowak N, Skupien J, Cyganek K, et al. 1,5-Anhydroglucitol as a marker of maternal glycaemic control and predictor of neonatal birth weight in pregnancies complicated by type 1 diabetes mellitus. Diabetologia 2013; 56:709-713.
46. Cyganek K, Hebda-Szydlo A, Katra B, et al. Glycemic control and selected pregnancy outcomes in type 1 diabetes women on continuous subcutaneous insulin infusion and multiple daily injections: the significance of pregnancy planning. Diabetes Technol Ther 2010; 12:41-47.
47. Brogden RN, Heel RC. Human insulin. A review of its biological activity, pharmacokinetics and therapeutic use. Drugs 1987; 34:350-371.
48. González Blanco C, Ballesteros AC, Saladich IG, et al. Glycemic control and pregnancy outcomes in women with type 1 diabetes mellitus using lispro versus regular insulin: a systematic review and meta-analysis. Diabetes Technol Ther 2011; 13:907-911.
49. Kinsley B. Achieving better outcomes in pregnancies complicated by type 1 and type 2 diabetes mellitus. Clin Ther 2007; 29 (Suppl D):S153-S160.
50. Mathiesen ER, Kinsley B, Amiel SA, et al. Insulin Aspart Pregnancy Study Group. Maternal glycemic control and hypoglycemia in type 1 diabetic pregnancy: a randomized trial of insulin aspart versus human insulin in 322 pregnant women. Diabetes Care 2007; 30:771-776.
51. Hod M, Damm P, Kaaja R, et al. Insulin Aspart Pregnancy Study Group. Fetal and perinatal outcomes in type 1 diabetes pregnancy: a randomized study comparing insulin aspart with human insulin in 322 subjects. Am J Obstet Gynecol 2008; 198:186-193.
52. Garnock-Jones KP, Plosker GL. Insulin glulisine: a review of its use in the management of diabetes mellitus. Drugs 2009; 69:1035-1057.
53. Lapolla A, Di Cianni G, Bruttomesso D, et al. Use of insulin detemir in pregnancy: a report on 10 type 1 diabetic women. Diabet Med 2009; 26:1181-1182.
54. Lepercq J, Lin J, Hall GC, et al. Meta-analysis of maternal and neonatal outcomes associated with the use of insulin glargine versus NPH insulin during pregnancy. Obstet Gynecol Int 2012; 2012:649070.
55. Mathiesen ER, Hod M, Ivanisevic M, et al. Detemir in Pregnancy Study Group: maternal efficacy and safety outcomes in a randomized, controlled trial comparing insulin detemir with NPH insulin in 310 pregnant women with type 1 diabetes. Diabetes Care 2012; 35:2012-2017.
56. Pearson ER, Starkey BJ, Powell RJ, et al. Genetic cause of hyperglycaemia and response to treatment in diabetes. Lancet 2003; 362:1275-1281.
57. Pearson ER, Flechtner I, Njølstad PR, et al. Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations. N Engl J Med 2006; 355:467-477.
58. Gaal Z, Klupa T, Kantor I, et al. Sulfonylurea use during entire pregnancy in diabetes because of KCNJ11 mutation: a report of two cases. Diabetes Care 2012; 35:e40.